2-Hydroxyisobutyrylation and Phosphorylation Crosstalk Guides Metastasis Prediction and Immunotherapy in Esophageal Squamous Cell Carcinoma.
Saved in:
| Title: | 2-Hydroxyisobutyrylation and Phosphorylation Crosstalk Guides Metastasis Prediction and Immunotherapy in Esophageal Squamous Cell Carcinoma. |
|---|---|
| Authors: | Li J; The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China; State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer School of Convergence Medicine Zhengzhou University Zhengzhou China., Li S; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., Yu X; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., Mu Q; The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou China., Luo M; State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease Department of Thoracic Surgery and Oncology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China., Wang Y; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., Liu Z; Department of Thoracic Surgery Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China., Gu C; Department of Thoracic Surgery The First Affiliated Hospital of Henan Medical University Xinxiang China., Chen J; The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou China., He W; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., Yang T; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., He Y; The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou China., Pei X; The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou China., Lin M; The Fifth Affiliated Hospital Guangzhou Medical University Guangzhou China.; Dongguan Key Laboratory of Precision Medicine Precision Medicine Center The First Dongguan Affiliated Hospital Guangdong Medical University Guangdong China., Li Z; Department of Thoracic Surgery Shanghai Chest Hospital Shanghai Jiao Tong University School of Medicine Shanghai China., Liu J; State Key Laboratory of Respiratory Disease and National Clinical Research Center for Respiratory Disease Department of Thoracic Surgery and Oncology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China., Zhao B; Department of Thoracic Surgery The First Affiliated Hospital of Henan Medical University Xinxiang China., Zhang F; Department of Gastrointestinal Surgery The Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou China., Liu J; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China., Li B; The Fifth Affiliated Hospital, Guangzhou Medical University, Guangzhou, China; State Key Laboratory of Metabolic Dysregulation and Prevention and Treatment of Esophageal Cancer School of Convergence Medicine Zhengzhou University Zhengzhou China., Xu W; Guangdong Provincial Key Laboratory of Protein Modification and Degradation School of Basic Medical Sciences, The Affiliated Traditional Chinese Medicine Hospital Guangzhou Medical University Guangzhou China. |
| Source: | MedComm [MedComm (2020)] 2026 Jun 19; Vol. 7 (7), pp. e70815. Date of Electronic Publication: 2026 Jun 19 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: China NLM ID: 101769925 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-2663 (Electronic) Linking ISSN: 26882663 NLM ISO Abbreviation: MedComm (2020) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2688-2663 |
|---|---|
| DOI: | 10.1002/mco2.70815 |
